Arrowhead Pharmaceuticals
ARWR
#2176
Rank
โ‚ฌ7.29 B
Marketcap
52,77ย โ‚ฌ
Share price
-4.98%
Change (1 day)
136.15%
Change (1 year)

Revenue for Arrowhead Pharmaceuticals (ARWR)

Revenue in 2025 (TTM): โ‚ฌ0.52 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.49 Billion. In 2024 the company made a revenue of โ‚ฌ2.4 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.52 B21860.76%
2024 โ‚ฌ2.4 M-98.54%
2023 โ‚ฌ0.16 B-36.64%
2022 โ‚ฌ0.25 B103.47%
2021 โ‚ฌ0.12 B96.46%
2020 โ‚ฌ64.91 M-55.55%
2019 โ‚ฌ0.14 B253.27%
2018 โ‚ฌ41.33 M62.34%
2017 โ‚ฌ25.46 M497.83%
2016 โ‚ฌ4.25 M1726.29%
2015 โ‚ฌ0.23 M-6.08%
2014 โ‚ฌ0.24 M95.96%
2013 โ‚ฌ0.12 M-40.55%
2012 โ‚ฌ0.21 M1055.32%
2011 โ‚ฌ0.01 M-99.45%
2010 โ‚ฌ3.35 M49.51%
2009 โ‚ฌ2.24 M95.48%
2008 โ‚ฌ1.14 M
2006 โ‚ฌ0.26 M-55.46%
2005 โ‚ฌ0.6 M
2002 โ‚ฌ0 M-61.61%
2001 โ‚ฌ0 M-76.74%
2000 โ‚ฌ0.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alnylam Pharmaceuticals
ALNY
โ‚ฌ2.75 B 460.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ0.16 B-66.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.21 B-56.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
โ‚ฌ0.15 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 15,982.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚ฌ1.89 B 284.31%๐Ÿ‡บ๐Ÿ‡ธ USA